Skip to main content

ORIGINAL RESEARCH article

Front. Neurol.
Sec. Artificial Intelligence in Neurology
Volume 15 - 2024 | doi: 10.3389/fneur.2024.1408457
This article is part of the Research Topic Exploring the Future of Neurology: How AI is Revolutionizing Diagnoses, Treatments, and Beyond View all 6 articles

Machine Learning-Based Prediction of Early Neurological Deterioration After Intravenous Thrombolysis for Stroke: Insights from a Large Multicenter Study

Provisionally accepted
Rui Wen Rui Wen 1Miaoran Wang Miaoran Wang 2*Wei Bian Wei Bian 3*Haoyue Zhu Haoyue Zhu 4*Ying Xiao Ying Xiao 3*Jing Zeng Jing Zeng 5*Qian He Qian He 4*钰 王 钰 王 4Xiaoqing Liu Xiaoqing Liu 4*Yangdi Shi Yangdi Shi 4*linzhi Zhang linzhi Zhang 4*Zhe Hong Zhe Hong 3*Bing Xu Bing Xu 4*
  • 1 Chongqing Nursing Vocational College, Chongqing, China
  • 2 Central Hospital Affiliated to Shenyang Medical College, Shenyang, Liaoning Province, China
  • 3 Shenyang First People’s Hospital, Shenyang Brain Institute, Shenyang, Liaoning Province, China
  • 4 Shenyang Tenth People's Hospital, Shenyang, Liaoning Province, China
  • 5 Chongqing Medical University, Chongqing, China

The final, formatted version of the article will be published soon.

    Background: This investigation seeks to ascertain the efficacy of various machine learning models in forecasting Early Neurological Deterioration (END) following thrombolysis in patients with acute ischemic stroke (AIS). Methods: Employing data from the Shenyang Stroke Emergency Map database, this multicenter study compiled information on 7,570 AIS patients from 29 comprehensive hospitals who received thrombolytic therapy between January 2019 and December 2021. An independent testing cohort was constituted from 2,046 patients at the First People's Hospital of Shenyang. The dataset incorporated 15 pertinent clinical and therapeutic variables. The principal outcome assessed was the occurrence of END post-thrombolysis. Model development was executed using an 80/20 split for training and internal validation, employing classifiers like logistic regression with lasso regularization (Lasso regression), Support Vector Machine (SVM), Random Forest (RF), Gradient-Boosted Decision Tree (GBDT), and Multi-Layer Perceptron (MLP). The model with the highest Area Under the Curve (AUC) was utilized to delineate feature significance. Results: Baseline characteristics showed variability in END incidence between the training (n=7,570; END incidence 22%) and external validation cohorts (n=2,046; END incidence 10%; P<0.001). Notably, all machine learning models demonstrated superior AUC values compared to the reference model, indicating their enhanced predictive capacity. The Lasso regression model achieved the highest AUC at 0.829 (95% CI: 0.799-0.86; P<0.001), closely followed by the MLP model with an AUC of 0.828 (95% CI: 0.799-0.858; P<0.001). The SVM, RF, and GBDT models also showed commendable AUCs of 0.753, 0.797, and 0.774, respectively. Decision curve analysis revealed that the SVM and MLP models demonstrated a high net benefit. Feature importance analysis emphasized 'Onset To Needle Time' and 'Admission NIHSS Score' as significant predictors. Conclusions: Our research establishes the MLP and Lasso regression as robust tools for predicting early neurological deterioration in acute ischemic stroke patients following thrombolysis. Their superior predictive accuracy, compared to traditional models, highlights the significant potential of machine learning approaches in refining prognosis and enhancing clinical decisions in stroke care management. This advancement paves the way for more tailored therapeutic strategies, ultimately aiming to improve patient outcomes in clinical practice.

    Keywords: machine learning, early neurological deterioration (END), Intravenous thrombolysis (IVT), Multicenter study design, Prediction model

    Received: 28 Mar 2024; Accepted: 29 Aug 2024.

    Copyright: © 2024 Wen, Wang, Bian, Zhu, Xiao, Zeng, He, 王, Liu, Shi, Zhang, Hong and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Miaoran Wang, Central Hospital Affiliated to Shenyang Medical College, Shenyang, Liaoning Province, China
    Wei Bian, Shenyang First People’s Hospital, Shenyang Brain Institute, Shenyang, 110041, Liaoning Province, China
    Haoyue Zhu, Shenyang Tenth People's Hospital, Shenyang, 110044, Liaoning Province, China
    Ying Xiao, Shenyang First People’s Hospital, Shenyang Brain Institute, Shenyang, 110041, Liaoning Province, China
    Jing Zeng, Chongqing Medical University, Chongqing, 400016, China
    Qian He, Shenyang Tenth People's Hospital, Shenyang, 110044, Liaoning Province, China
    Xiaoqing Liu, Shenyang Tenth People's Hospital, Shenyang, 110044, Liaoning Province, China
    Yangdi Shi, Shenyang Tenth People's Hospital, Shenyang, 110044, Liaoning Province, China
    linzhi Zhang, Shenyang Tenth People's Hospital, Shenyang, 110044, Liaoning Province, China
    Zhe Hong, Shenyang First People’s Hospital, Shenyang Brain Institute, Shenyang, 110041, Liaoning Province, China
    Bing Xu, Shenyang Tenth People's Hospital, Shenyang, 110044, Liaoning Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.